Patents by Inventor Boris Shor

Boris Shor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10617670
    Abstract: This invention relates to combinations of an auristatin or an auristatin-based antibody-drug-conjugate (ADC) with second active agents including PI3K/mTOR inhibitors, MEK inhibitors, taxanes, or other anti-cancer agents, and methods of treating abnormal cell growth by administering these combinations to patients.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: April 14, 2020
    Assignee: Pfizer Inc.
    Inventors: Puja Sapra, Boris Shor
  • Publication number: 20180228769
    Abstract: This invention relates to combinations of an auristatin or an auristatin-based antibody-drug-conjugate (ADC) with second active agents including PI3K/mTOR inhibitors, MEK inhibitors, taxanes, or other anti-cancer agents, and methods of treating abnormal cell growth by administering these combinations to patients.
    Type: Application
    Filed: September 29, 2015
    Publication date: August 16, 2018
    Inventors: Puja Sapra, Boris Shor